Skip to content
TrialScanner

NCT04872608

A Study of Letrozole, Palbociclib, and Onapristone ER in People With Metastatic Breast Cancer

Phase 1WithdrawnCNTXCollaborator

Registry record

Lead sponsor
Memorial Sloan Kettering Cancer Center
Conditions
Metastatic Breast Cancer; Unresectable Breast Cancer
Primary completion
Apr 25, 2023Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT04872608 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT04872608: A Study of Letrozole... | TrialScanner